David Perritt

Prior to joining Rondaxe in 2012 Dave founded Forefront Pharma, a medical device sales and distribution company. After leading the company to eight figure sales, Dave transitioned from Forefront Pharma into testing software for web based applications for the banking industry. After cutting his teeth in software sales, he then moved into the pharmaceutical industry and connected with Rondaxe in order to move their CMC Data Management and Cost of Goods Analysis software from internal tools to mainstream marketed products. Dave is currently Vice President at Resource Pharma Solutions, where he facilitates users in becoming familiar with Resource Pharma Solutions unique software products created for the pharma industry by the pharma industry.

Recent Posts

The Days of Clean Sheeting for Cost of Goods are Over.

Posted by David Perritt on Mar 5, 2018 9:30:00 AM

We have all been there when we need to determine various costs and where they come from.  We stare at spreadsheets, trying to gather the necessary data, critical and nonessential, and using our calculations to determine how we can lower costs.  This approach is not only time consuming, but inaccurate and inefficient, but what are the alternatives?

Read More

Is Excel Holding You Back?

Posted by David Perritt on Jan 22, 2018 9:26:00 AM

Is Excel a dated method of data crunching that is holding back rather than advancing your company? CFOs from Fortune 500 companies are insisting that staff stop using Excel. What does that mean for the pharmaceutical industry, and why is there push back against the popular spreadsheet software? Finance chiefs say the ubiquitous spreadsheet software that revolutionized accounting in the 1980s cannot kept up with the demands of contemporary corporate finance units. After all, just like hair metal bands, the 80s are long gone and pharmaceutical companies need to advance with the times.

Spreadsheets have been a necessary and advantageous tool in a huge number of industries. Excel has revolutionized accounting and driven decision making, but as business becomes more complex and global, Excel cannot bear the expectations and demands of many companies.

Read More

Topics: Data Management, Cost Analysis, healthcare

Exercise Can Prevent Dementia; Why Pharma Companies Should Care

Posted by David Perritt on Aug 11, 2017 11:30:00 AM


Alzheimer’s is a progressive, neurodegenerative disease characterized by memory loss and impaired cognition, with as many as 5.4 million Americans living with the disease.  Today Alzheimer's disease is the sixth leading cause of death in the United States and the 5th leading cause for those 65 and older.  The symptoms of Alzheimer's slowly creep into our lives and affect loved ones in profound ways.  Throughout the years, research and medications have helped, hindered and or even prevented some of the serious symptoms, but currently, there is no cure.

Read More

Topics: Pharma and Politics

Cost versus Quality:  Is Manufacturing in India Worth It?

Posted by David Perritt on Jun 5, 2017 1:44:53 PM

Six months into an administration’s promise to curb drug prices, the cost of drug development remains high.  As companies scramble to reduce costs, they are moving manufacturing overseas, enticed by lucrative savings.  The question remains: are drug companies really saving money or are reduced costs in production aligned with quality, timeline and regulation issues?

Read More

Topics: Business

Cost vs Price:  How Can You Maximize Value?

Posted by David Perritt on May 9, 2017 11:20:00 AM

Recently, in a forum setting, a panel discussion touched upon cost versus price and how best to address the potentially touchy issues of cost versus pricing. With recent consumer outrage over drug pricing and demands for cost controls, this is a hot button issue for both drug companies and the people they serve.

A great deal of attention has been placed on the price of drugs; some have even called price increases gouging, but to paraphrase a panel commentator – ‘Beats’ headphones have margins on their products much hihger than pharma and nobody seems to care about that."  Although this is a true statement, to be fair, nobody's grandma has ever died without their "Beats."  Perhaps there is a way to let grandma have her Beats AND her heart medication.  With that statement in mind let’s explore the top three ways to optimize both cost and pricing:  choosing the right CMO, maximizing communication, reducing errors and celebrating innovation.

Read More

Topics: Data Management

Standardizing Laboratory Data:  Next Great Idea or Necessary Evil?

Posted by David Perritt on Apr 24, 2017 12:02:01 PM

A very close and trustworthy colleague in the industry has stated that the magic of the lab is the absolute random, disarray of work that leads to producing the best drugs.  The way that different pharma companies operate during the drug development process and the way they collect, analyze and distribute the data is unique to that company.

Result: The successful drugs we have today.

On the other hand, industry pressure, government regulations and financial responsibilities have pharma looking inward to see how changes in the drug development and manufacturing process can be streamlined and efficient.  A common answer to the problem of efficiency is standardization.  There are multiple benefits of standardized data:  better communication, savings of time and resources, ease of comparison and enhances collaboration between scientists and outside partners.  According to Nicola Tambascia of Clinipace, more regulatory agencies worldwide are beginning to require standardized data as part of the submission process.

Read More

Topics: Data Management

Five Tips To Make Your Data Work For You

Posted by David Perritt on Apr 19, 2017 11:37:00 AM


"Scientists spend greater than 50 percent of their time searching for data that already exists."

-Allotrope Foundation

Does your data have a purpose? If not, you may be missing an opportunity--or worse, wasting your time collecting random bits of information. Here are the top five tips to ensure that your data is working for you.


Integrity is a key component of putting your data to good use.  Technology has improved exponentially over the years to allow for document organization, data management and overall informatics control.  Control is the key when it comes to data integrity.  The ability to control your data is fundamental in guaranteeing the integrity of your data; a critical component of regulatory submissions and documentation.  Choosing the right tools to control data is imperative.  Not all tools require validation, but a solution should have the ability to trace data for consistent recall for submission and filing purposes.  Control your data and it's integrity, and you will save yourself untold amounts of time and headache when it's time to submit your documents.

Read More

Topics: Data Management

Data Integrity and the Increasing Complexity of Your Data

Posted by David Perritt on Apr 11, 2017 11:12:00 AM

In this day and age there are multiple organizations whose sole purposed is to collect, organize and interpret your data.  Data has never been more critical, and the use and interpretation of it become even more important every day.  But how can we capitalize on using every bit of our data to increase our output effectively?

To ensure safety and efficacy, any data associated with a pharmaceutical product must be “attributable, legitimate, contemporaneous, original, and accurate.”

-Darren Barrington-Light, Biopharm International

Read More

Topics: Data Management

Five Tips To Effectively Manage Drug Manufacturing Costs

Posted by David Perritt on Apr 4, 2017 11:40:00 AM


Inspirational words, and worthwhile goals to aspire to in manufacturing drugs to improve the lives of countless people.Somewhere in between the idea and the bottle of pills on the shelf, there is the process of manufacturing drugs and the costs associated with that endeavor.  With the increased scrutiny of the public in regards to the cost of drugs, keeping the cost of manufacturing controlled is more important than ever before.

Read More

Topics: Pharma Pricing, Cost Analysis

Are Mergers and Acquisitions Defining Pharma?

Posted by David Perritt on Mar 27, 2017 11:20:00 AM

Certain industries undergo mergers and acquisitions more often than others.  Industries with a significant global market share are attractive for other companies, investors or venture capitalists that see a huge upside and immediate return on investment.  Although merger and acquisition activity is common in many industries, in the pharmaceutical industry it has noticeably reduced the number of major companies over the past 15 years. The short-term business rationale for this extensive consolidation might have been reasonable, but at what cost to research and development productivity? 

Read More

Topics: Business